Quick Answer
AVANOS MEDICAL, INC. reported R&D Expense of $23.30 million for fiscal year 2025.
AVANOS MEDICAL, INC. R&D Expense — Annual History
| Fiscal Year | R&D Expense | YoY Change |
|---|---|---|
| 2025 | $23.30M | -11.1% |
| 2024 | $26.20M | -3.7% |
| 2023 | $27.20M | -6.8% |
| 2022 | $29.20M | -4.6% |
| 2021 | $30.60M | -12.3% |
| 2020 | $34.90M | -7.4% |
| 2019 | $37.70M | -9.8% |
| 2018 | $41.80M | +9.4% |
| 2017 | $38.20M | -0.5% |
| 2016 | $38.40M | +39.1% |
| 2015 | $27.60M | -17.9% |
| 2014 | $33.60M | -11.3% |
| 2013 | $37.90M | +14.8% |
| 2012 | $33.00M | — |
Quarterly R&D Expense
| Quarter Ending | R&D Expense | YoY | QoQ |
|---|---|---|---|
| September 30, 2025 | $6.00M | -16.7% | +3.4% |
| June 30, 2025 | $5.80M | -7.9% | +7.4% |
| March 31, 2025 | $5.40M | -22.9% | -25.0% |
| September 30, 2024 | $7.20M | +18.0% | +14.3% |
| June 30, 2024 | $6.30M | -7.4% | -10.0% |
| March 31, 2024 | $7.00M | -6.7% | +14.8% |
| September 30, 2023 | $6.10M | -14.1% | -10.3% |
| June 30, 2023 | $6.80M | -10.5% | -9.3% |
- AVANOS MEDICAL, INC. showed a decrease of -11.1% in R&D Expense compared to the prior fiscal year.
- Over the 2012–2025 period, AVANOS MEDICAL, INC.’s r&d expense has declined by 29.4% (from $33.00 million to $23.30 million).
- The most recent figure is from AVANOS MEDICAL, INC.’s fiscal year 2025 report (Form 10-K), filed with the SEC on February 24, 2026.
- All figures are sourced from SEC EDGAR XBRL filings, last verified June 17, 2026.
Last verified: